IGF1R and breast cancer: These findings are consistent with a previous report showing that a breast cancer cell line with high IR:IGF1R expression ratio (MDAMB231) was more sensitive to IR blockade than a cell line with a low IR:IGF1R expression ratio (MCF7) [31].